Teleflex Incorporated - Asset Resilience Ratio
Teleflex Incorporated (TFX) has an Asset Resilience Ratio of 4.50% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Teleflex Incorporated total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2024)
This chart shows how Teleflex Incorporated's Asset Resilience Ratio has changed over time. See TFX book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Teleflex Incorporated's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TFX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $354.00 Million | 4.5% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $354.00 Million | 4.50% |
Asset Resilience Insights
- Limited Liquidity: Teleflex Incorporated maintains only 4.50% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Teleflex Incorporated Industry Peers by Asset Resilience Ratio
Compare Teleflex Incorporated's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Teleflex Incorporated (2010–2024)
The table below shows the annual Asset Resilience Ratio data for Teleflex Incorporated.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.31% | $306.16 Million | $7.10 Billion | +1.13pp |
| 2023-12-31 | 3.18% | $239.73 Million | $7.53 Billion | -1.73pp |
| 2022-12-31 | 4.92% | $340.54 Million | $6.93 Billion | -1.88pp |
| 2021-12-31 | 6.79% | $466.80 Million | $6.87 Billion | +1.26pp |
| 2020-12-31 | 5.54% | $395.99 Million | $7.15 Billion | +0.42pp |
| 2019-12-31 | 5.11% | $322.66 Million | $6.31 Billion | -0.81pp |
| 2018-12-31 | 5.92% | $371.89 Million | $6.28 Billion | +0.53pp |
| 2017-12-31 | 5.40% | $333.56 Million | $6.18 Billion | -8.58pp |
| 2016-12-31 | 13.97% | $543.79 Million | $3.89 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $3.88 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $3.98 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $4.21 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $3.74 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $3.92 Billion | -- |
| 2010-12-31 | 0.00% | $0.00 | $3.64 Billion | -- |
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation an… Read more